Biography
- Attending Physician, Infectious Disease, Ann & Robert H. Lurie Children’s Hospital of Chicago
- Associate Professor of Pediatrics (Infectious Diseases), Northwestern University Feinberg School of Medicine
See Lurie Children's Provider Profile
Dual certified in Internal Medicine and Pediatrics, Jennifer Jao, MD, MPH, is an Associate Professor in the Departments of Pediatric and Adult Infectious Diseases at Northwestern University Feinberg School of Medicine. She is a member of the U.S. Panel on the Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission Guidelines Panel; Co-Chair of the International Maternal Pediatric Adolescent AIDS Clinical Trials network P1115 “Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission” protocol; and Co-Chair of the Nutrition, Growth, and Metabolic Working Group in the Pediatric HIV/AIDS Cohort Study. Dr. Jao leads multiple NIH-funded pediatric and maternal-pediatric HIV cohorts both in the United States and Africa. As a translational researcher, Dr. Jao targets her research portfolio to the long-term metabolic effects of HIV and antiretroviral therapy.
Education and Background
- Infectious Disease Fellowship, Icahn School of Medicine at Mount Sinai 2010
- MPH, Icahn School of Medicine at Mount Sinai 2010
- Internal Medicine and Pediatrics Residency, Rush University Medical Center 2002
- MD, Medical College of Georgia 1998
Featured Grants
ORCHID—Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir
National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development
09/25/2020 → 06/01/2025
Understanding Inflammatory and Metabolic Pathways of Myocardial and Vascular Dysfunction in South African Youth Living with Perinatal HIV
National Institutes of Health/National Heart, Lung, and Blood Institute
05/01/2020 → 04/01/2025
The Tshilo Dikotla Study: Metabolic Outcomes of Children HIV/ARV-exposed Uninfected in Botswana
National Institute of Diabetes and Digestive and Kidney Diseases
04/18/2017 → 03/31/2022
Pediatric HIV/AIDS Cohort Study (PHACS)
National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development
09/01/2020 → 07/31/2025
FLOURISH—Following Longitudinal Outcomes to Understand, Report, Intervene and Sustain Health of Infants, Children and Adolescents who are HIV Exposed Uninfected
National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development
08/17/2020 → 06/30/2022
IMPAACT Leadership Group—P1115 Protocol: Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission: A Phase I/II Proof of Concept Study
National Institutes of Health/National Institute of Allergy and Infectious Diseases
12/01/2020 → 11/30/2026
